Urothelial papilloma
Urothelial papilloma is a rare, benign tumor that originates in the urinary bladder's urothelial cells. It is characterized by a fibrovascular core covered by normal-appearing urothelial cells.
Epidemiology[edit]
Urothelial papilloma is a rare condition, accounting for less than 1% of all urinary bladder tumors. It is more common in males than in females and typically occurs in the fifth to sixth decade of life.
Pathology[edit]
Urothelial papilloma is characterized by a fibrovascular core covered by normal-appearing urothelial cells. The urothelial cells are uniform in size and shape, with no significant nuclear atypia or mitotic activity. The underlying stroma may show mild inflammation.
Clinical Presentation[edit]
Patients with urothelial papilloma typically present with hematuria, which is often microscopic. Other symptoms may include urinary frequency, urgency, and dysuria. However, many patients are asymptomatic, and the tumor is discovered incidentally during imaging studies for other conditions.
Diagnosis[edit]
The diagnosis of urothelial papilloma is made by cystoscopy and biopsy. The tumor appears as a small, solitary, papillary lesion on cystoscopy. Histologically, the tumor is characterized by a fibrovascular core covered by normal-appearing urothelial cells.
Treatment[edit]
The treatment of choice for urothelial papilloma is transurethral resection. This procedure involves the removal of the tumor using a resectoscope inserted through the urethra. Following resection, patients are typically followed with periodic cystoscopy to monitor for recurrence.
Prognosis[edit]
The prognosis for patients with urothelial papilloma is generally excellent. The tumor is benign and does not invade the bladder wall or metastasize to other sites. However, there is a risk of recurrence, and some patients may develop urothelial carcinoma in situ or invasive urothelial carcinoma.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
